Trial site
Norton Cancer Institute, Downtown
- 13running trials
- 6closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Lung cancer9 trials
- Head and neck cancer5 trials
- Colorectal cancer3 trials
- Cervical cancer2 trials
- Liver and biliary tract cancer2 trials
- Metastatic breast cancer2 trials
- Pancreatic cancer2 trials
- Bladder cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Melanoma1 trial
- Prostate cancer1 trial
- and 1 more
- Phase
- Phase 38 trials
- Phase 27 trials
- Phase 13 trials
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Completed5 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Pfizer5 trials
- Seagen, a wholly owned subsidiary of Pfizer5 trials
- Boehringer Ingelheim3 trials
- Amgen1 trial
- Lisata Therapeutics, Inc.1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Active, not recruiting
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
Closed trials
Recruiting
Completed
Completed
Recruiting
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Completed
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Site data: ClinicalTrials.govUpdated 18 Nov 2026